Despite initial hopes, the efficacy of tumour necrosis factor in treating cancer patients has been disappointing. But a more careful selection of patients, and more appropriate treatment, might be fruitful.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Intratumoral microorganisms in tumors of the digestive system
Cell Communication and Signaling Open Access 25 January 2024
-
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Cell Death Discovery Open Access 20 January 2024
-
Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
Scientific Reports Open Access 02 August 2023
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Coley, W. B. Practitioner 83, 589–613 (1909).
Nauts, H. C. et al. Can. Res. 6, 205–216 (1946).
Harmer, T. W. Boston Med. Surg. J. 171, 253 (1914).
Johnston, B. J. & Novales, E. T. Can. Chem. Rep. No. 21, 43–68 (1962).
Axelrod, R. S. et al. Cancer 61, 2219–2230 (1988).
Tichatschek, E. et al. Can. Immun. Immunother. 27, 278–282 (1988).
Berendt, M. J. et al. J. exp. Med. 148, 1560 (1978).
Demetri, G. D. et al. J. clin. Oncol. 7, 1545 (1989).
Spriggs, D. R. & Yates, S. W. in Tumor Necrosis Factors (ed. Beutler, B.) 394 (Raven, New York, 1992).
Carswell, E. A. et al. Proc. natn. Acad. Sci. U.S.A. 72, 3666–3670 (1975).
McIntosh, J. K. et al. Can. Res. 49, 1408–1414 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Starnes, C. Coley's toxins in perspective. Nature 357, 11–12 (1992). https://doi.org/10.1038/357011a0
Issue Date:
DOI: https://doi.org/10.1038/357011a0